Asian Diabetes Outcomes Prevention Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2400 participants.
Also called NCT04286399
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 2,400 participants
- Sponsor
- Registry
-
NCT04286399
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Singapore
- Registry status
- Recruiting
Technical summary
Registry record NCT04286399. Randomized; no masking; primary purpose treatment. Start 2019-07-01 (actual); primary completion 2022-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Asian Diabetes Outcomes Prevention Trial
- Acronym
- ADOPT
- Condition
- Diabetes Mellitus
- Condition
- Cardiovascular Diseases
- Intervention (Drug)
- Renin-angiotensin-aldosterone system inhibitors
- Intervention (Drug)
- Beta blocker
- Intervention (Drug)
- SGLT2 Inhibitor - Sodium Glucose Cotransporter Subtype 2 Inhibitor Product
- Lead sponsor
- National Heart Centre Singapore
- Collaborator
- Singapore General Hospital
- Collaborator
- Mackay Memorial Hospital
- Collaborator
- National Taiwan University Hospital
- Collaborator
- Peking University People's Hospital
- Collaborator
- Medanta, The Medicity, India
- Collaborator
- Public Health Foundation of India
- Collaborator
- Putrajaya Hospital, Malaysia
- Collaborator
- Universiti Teknologi Mara
Record details
- Record id
cardio:ct-nct04286399- Content hash
7caaf55f70b365d133f68284f8a7a258f362d5af520e17bf7be5e715bd7d1d6b